{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T17:11:34Z","timestamp":1769879494810,"version":"3.49.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1016\/j.femsim.2004.03.005","type":"journal-article","created":{"date-parts":[[2004,4,10]],"date-time":"2004-04-10T09:40:04Z","timestamp":1081590004000},"page":"205-210","source":"Crossref","is-referenced-by-count":13,"title":["Adjuvant can improve protection induced by OMV vaccine against<i>Neisseria meningitidis<\/i>serogroups B\/C in neonatal mice"],"prefix":"10.1093","volume":"41","author":[{"given":"Lucila O","family":"Fukasawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waldely O","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocilda P.F","family":"Schenkman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Raw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha M","family":"Tanizaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1016\/j.femsim.2004.03.005-BIB1","first-page":"975","article-title":"Meningococcal vaccines","volume":"3","author":"Collins","year":"2002","journal-title":"Curr. Opin. Invest. Drugs"},{"key":"10.1016\/j.femsim.2004.03.005-BIB2","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1086\/344324","article-title":"Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United Kingdom","volume":"186","author":"Borrow","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.femsim.2004.03.005-BIB3","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(03)12563-9","article-title":"Effectiveness of meningococcal C conjugate vaccine in teenagers in England","volume":"361","author":"Bose","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.femsim.2004.03.005-BIB4","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1086\/368358","article-title":"Immunogenicity and immunological priming of the serogroup a portion of a bivalent meningococcal A\/C conjugate vaccine in 2-year-old children","volume":"187","author":"Joseph","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.femsim.2004.03.005-BIB5","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4049\/jimmunol.138.12.4402","article-title":"An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysalic acid units of glicoproteins in neural and extraneural tissues","volume":"138","author":"Finne","year":"1987","journal-title":"J. Immunol."},{"key":"10.1016\/j.femsim.2004.03.005-BIB6","unstructured":"[6] Zollinger, W.D (1997) New and improved vaccines against meningococcal disease. In: New Generation Vaccines (Levine, M.M, Woodrow, G.C, Kaper, J.B, Cobon, G.S, Eds.), pp.469\u00e2\u0080\u0093488 Marcel Dekker, New York."},{"key":"10.1016\/j.femsim.2004.03.005-BIB7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00006454-200004000-00015","article-title":"Vaccines for prevention of meningococcal disease","volume":"19","author":"Pollard","year":"2000","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.femsim.2004.03.005-BIB8","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1128\/IAI.62.10.4419-4424.1994","article-title":"Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy","volume":"62","author":"Milagres","year":"1994","journal-title":"Infect. Immun."},{"key":"10.1016\/j.femsim.2004.03.005-BIB9","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/ije\/24.5.1050","article-title":"Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case control study","volume":"24","author":"Noronha","year":"1995","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.femsim.2004.03.005-BIB10","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1016\/S0264-410X(02)00151-2","article-title":"Avidity maturation following vaccination with a meningococcal recombinant haxavalent PorA OMV vaccine in UK infants","volume":"20","author":"Lonsworth","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.femsim.2004.03.005-BIB11","first-page":"224","article-title":"Humoral immune responses to Neisseria meningitids in children","volume":"67","author":"Pollard","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.femsim.2004.03.005-BIB12","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0140-6736(00)03405-X","article-title":"Production of low avidity antibody by infants after infection with serogroup B meningococci","volume":"356","author":"Pollard","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.femsim.2004.03.005-BIB13","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1016\/S0264-410X(99)00177-2","article-title":"Neisseria meningitidis serogroup C polysaccharide and serogroup B outer membrane vesicle conjugate as a bivalent meningococcus vaccine candidate","volume":"17","author":"Fukasawa","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.femsim.2004.03.005-BIB14","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/S0264-410X(98)00062-0","article-title":"Effect of adjuvants in the isotypes and bactericidal activity of antibodies against the transferrin-binding proteins of Neisseria meningitidis","volume":"16","author":"G\u00c3\u00b3mes","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.femsim.2004.03.005-BIB15","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1128\/IAI.67.10.4988-4993.1999","article-title":"Immunogenicity of outer membrane proteins in a lipopolysaccharide-deficient mutant of Neisseria meningitidis: influence of adjuvants on the immune response","volume":"67","author":"Steeghs","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.femsim.2004.03.005-BIB16","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/infdis\/158.4.710","article-title":"Antibody response of adults to an aluminum hydroxide-adsorbed Neisseria meningitidis serotype 2b protein group B polysaccharide vaccine","volume":"158","author":"Frasch","year":"1988","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.femsim.2004.03.005-BIB17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1128\/CDLI.5.4.479-485.1998","article-title":"A modified enzyme-linked immunosorbent assay for measurement of antibody response to meningococcal C polysaccharide that correlate with bactericidal responses","volume":"5","author":"Granoff","year":"1998","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.femsim.2004.03.005-BIB18","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/IAI.70.2.584-590.2002","article-title":"Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outermembrane vesicle vaccine","volume":"70","author":"Vermont","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.femsim.2004.03.005-BIB19","first-page":"195","article-title":"Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"Sierra","year":"1991","journal-title":"NIPH Ann."},{"key":"10.1016\/j.femsim.2004.03.005-BIB20","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0264-410X(94)00037-N","article-title":"Efficacy, safety and immunogenicity of a meningococcal group B (15:P1.3) outer membrane vesicle vaccine in Iquique, Chile","volume":"13","author":"Bosleggo","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.femsim.2004.03.005-BIB21","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.281.16.1520","article-title":"Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile","volume":"281","author":"Tappero","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.femsim.2004.03.005-BIB22","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1440-1711.1998.00746.x","article-title":"Optimization of vaccine responses in early life: the role of delivery systems and immunomodulators","volume":"76","author":"Kovarik","year":"1998","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.femsim.2004.03.005-BIB23","first-page":"243","article-title":"Simultaneous administration of meningococcal C conjugate vaccine and diphteria-tetanus-acellular petussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: a randomized double-blind study","volume":"25","author":"Halperin","year":"2002","journal-title":"Clin. Invest. Med."},{"key":"10.1016\/j.femsim.2004.03.005-BIB24","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1128\/IAI.65.5.1710-1715.1997","article-title":"MF59 adjuvant enhances antibody responses of infant babbons immunized with Haemophilus influenzae type b and Neisseria meningitidis group C oligosccharide-CRM197 conjugate vaccine","volume":"65","author":"Granoff","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.femsim.2004.03.005-BIB25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0140-6736(86)90001-2","article-title":"Immunogenicity in infants of Haemophilus influenzae type b polysaccharide in a conjugate vaccine with Neisseria meningitids outer-membrane protein","volume":"2","author":"Einhorn","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.femsim.2004.03.005-BIB26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1749-6632.1994.tb44295.x","article-title":"Immunopotenciating ability of neisserial major outer membrane proteins","volume":"730","author":"Wetzler","year":"1994","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.femsim.2004.03.005-BIB27","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1084\/jem.183.3.1151","article-title":"Nesserial porins induce B lymphocytes to express coestimulatory B7\u00e2\u0080\u00932 molecules and to proliferate","volume":"183","author":"Wetzler","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.femsim.2004.03.005-BIB28","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1073\/pnas.89.10.4633","article-title":"A vaccine carrier derived from Neisseria meningitidis with mitogenic activity for lymphocytes","volume":"89","author":"Liu","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.femsim.2004.03.005-BIB29","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1002\/1521-4141(200108)31:8<2373::AID-IMMU2373>3.0.CO;2-G","article-title":"Carrier-mediated enhancement of cognate T cell help: the basis of enhanced immunogenicity of meningococcal outer membrane protein polysaccharide conjugate vaccine","volume":"31","author":"P\u00c3\u00a9rez-Melgosa","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.femsim.2004.03.005-BIB30","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1128\/JCM.39.8.2897-2903.2001","article-title":"Serosubtypes and Por A types of Neisseria meningitidis serogroup B isolated in Brazil during 1997\u00e2\u0080\u00931998: overview and implications for vaccine development","volume":"39","author":"Sacchi","year":"2001","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.femsim.2004.03.005-BIB31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1099\/jmm.0.05017-0","article-title":"Immune response to native NadA from Neisseria meningitidis and its expression in clinical isolates in Brazil","volume":"52","author":"Fukasawa","year":"2003","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.femsim.2004.03.005-BIB32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/exmp.2002.2429","article-title":"Antibodies to squalene in recipients of anthrax vaccine","volume":"73","author":"Asa","year":"2002","journal-title":"Exp. Mol. Path."},{"key":"10.1016\/j.femsim.2004.03.005-BIB33","first-page":"1331","article-title":"Increased immunogenicity of the MF-59 adjuvanted influenza vaccine compared to a conventional subunit vaccine in elderly subjects","volume":"184","author":"Gasparini","year":"2001","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.femsim.2004.03.005-BIB34","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1086\/368382","article-title":"Safety and immunogenicity of a recombinant parvovirus B19 vaccine formulated with MF59C","volume":"187","author":"Ballou","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.femsim.2004.03.005-BIB35","doi-asserted-by":"crossref","unstructured":"[35] Ott, G, Radhakrishnan, R, Fanf, J.H, Hora, M (2000) The adjuvant MF59: a 10 year perspective. In: Vaccine Adjuvants. Preparation Methods and Research Protocols (O'Hagan, D.T, Ed.), pp.211\u00e2\u0080\u0093228 Humana Press Inc, New Jersey.","DOI":"10.1385\/1-59259-083-7:211"}],"container-title":["FEMS Immunology &amp; Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femspd\/article-pdf\/41\/3\/205\/19167324\/41-3-205.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T07:17:01Z","timestamp":1682666221000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femspd\/article-lookup\/doi\/10.1016\/j.femsim.2004.03.005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,7]]}},"URL":"https:\/\/doi.org\/10.1016\/j.femsim.2004.03.005","relation":{},"ISSN":["0928-8244","1574-695X"],"issn-type":[{"value":"0928-8244","type":"print"},{"value":"1574-695X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}